000 01433 a2200409 4500
005 20250517221842.0
264 0 _c20190923
008 201909s 0 0 eng d
022 _a1098-6596
024 7 _a10.1128/AAC.00539-18
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aKato, Kelly C
245 0 0 _aEfficacy of Meglumine Antimoniate in a Low Polymerization State Orally Administered in a Murine Model of Visceral Leishmaniasis.
_h[electronic resource]
260 _bAntimicrobial agents and chemotherapy
_c08 2018
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAdministration, Oral
650 0 4 _aAnimals
650 0 4 _aCaco-2 Cells
650 0 4 _aDisease Models, Animal
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aLeishmaniasis, Visceral
_xdrug therapy
650 0 4 _aMeglumine Antimoniate
_xadministration & dosage
650 0 4 _aMice
650 0 4 _aMice, Inbred BALB C
650 0 4 _aPolymerization
700 1 _ade Morais-Teixeira, Eliane
700 1 _aIslam, Arshad
700 1 _aLeite, M Fatima
700 1 _aDemicheli, Cynthia
700 1 _ade Castro, Whocely V
700 1 _aCorrêa-Junior, José D
700 1 _aRabello, Ana
700 1 _aFrézard, Frédéric
773 0 _tAntimicrobial agents and chemotherapy
_gvol. 62
_gno. 8
856 4 0 _uhttps://doi.org/10.1128/AAC.00539-18
_zAvailable from publisher's website
999 _c28495360
_d28495360